Define Multiple Myeloma. Describe its clinical features, investigations and management.
Definition
Multiple myeloma is a malignant proliferation of plasma cells in the bone marrow producing a monoclonal immunoglobulin (paraprotein). Although a haematological malignancy, it is the commonest primary malignant tumour of bone and a key differential for destructive bone lesions in the older adult (typically > 60 years).
Clinical Features
Remembered by ‘crab’: hyperCalcaemia, Renal impairment, Anaemia and Bone lesions/Back pain. Patients present with bone pain (especially the spine), pathological fractures, fatigue from anaemia, recurrent infections and features of hypercalcaemia or renal failure.
Investigations
Blood/urine: monoclonal paraprotein on serum electrophoresis, Bence-Jones protein in urine, raised ESR, anaemia, hypercalcaemia, renal impairment and rouleaux on the film. Imaging classically shows multiple ‘punched-out’ lytic lesions (and diffuse osteopenia); note that the radionuclide bone scan is often negative because the lesions are purely lytic with little osteoblastic activity — a whole-body MRI/low-dose CT or skeletal survey is preferred. Bone-marrow biopsy confirms the plasma-cell infiltrate.
DANGER / REMEMBER
Do not rely on a bone scan to detect myeloma — the purely lytic deposits frequently do not light up. Use a skeletal survey, low-dose whole-body CT or MRI instead.
Management
Management is by haemato-oncology with systemic chemotherapy/novel agents (proteasome inhibitors, immunomodulators ± autologous stem-cell transplant), bisphosphonates for skeletal protection and hypercalcaemia, and supportive care. The orthopaedic role is stabilisation of pathological or impending fractures and radiotherapy/decompression for spinal cord compression.
Solitary Plasmacytoma
A single focus of malignant plasma cells in bone is a solitary plasmacytoma; it often presents with a destructive lytic lesion or a pathological (frequently vertebral) fracture and is treated with radiotherapy, but a large proportion progress to multiple myeloma over subsequent years, so continued haematological follow-up is required.
Bone scan is falsely negative — use skeletal survey.
KEY POINT
Key points TO remember
- Malignant plasma-cell proliferation; commonest primary bone malignancy; older adults.
- Crab: hyperCalcaemia, Renal impairment, Anaemia, Bone lesions/back pain.
- Paraprotein + Bence-Jones protein; ‘punched-out’ lytic lesions; bone scan often negative.
- Haemato-oncology treatment + bisphosphonates; orthopaedics stabilises fractures / treats cord compression.
EXAM TIP
Sources: Maheshwari's Essential Orthopaedics; Apley & Solomon's System of Orthopaedics and Trauma; AO Principles of Fracture Management.
All questions in Bone Tumours
- Q1Define Classification & Approach to a Bone Tumour. Describe its clinical features and management. ★
- Q2Define Osteosarcoma. Describe its clinical features, investigations, management and prognosis. ★
- Q3Define Ewing’s Sarcoma. Describe its clinical features, investigations, management and prognosis. ★
- Q4Giant Cell Tumour ★
- Q5Define Metastatic Bone Disease. Describe its clinical features, investigations, management and prognosis. ★
- SN1Define Osteochondroma. Describe its clinical features and management.
- SN2Define Osteoid Osteoma. Describe its clinical features and diagnosis. ★
- SN3Describe Enchondroma in detail.
- SN4Describe Periosteal Reactions & Codman’s Triangle in detail.
- SN5Define Multiple Myeloma. Describe its clinical features, investigations and management. ★
- SN6Describe Simple & Aneurysmal Bone Cysts in detail.
- SN7Define Pathological Fracture. Describe its causes and management. ★